REFILE-BRIEF-Photocure ASA to terminate the global licensing agreement for Lumacan

(Refiles to add a code for Salix Pharmaceuticals ) Aug 18 (Reuters) - Photocure ASA : * Says agreed to terminate the global licensing agreement for Lumacan with Salix Pharmaceuticals * Says Will receive a payment of US$ 5M from Salix and will regain the global rights and all intellectual property to Lumacan. * Source text for Eikon * Further company coverage
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.